Unity Biotechnology, Inc. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 3 rows, 3 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-05-02: Reporting owner David Nathaniel E; Form 3; Security Series A-1 Warrant; Transaction Holding.
- 2018-05-02: Reporting owner David Nathaniel E; Form 3; Security Series A-2 Warrant; Transaction Holding.
- 2018-05-02: Reporting owner David Nathaniel E; Form 3; Security Series A-2 Warrant; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-05-02 holding as of filing | David Nathaniel E Director, Officer (President) | 3 | Series A-1 Warrant Derivative · Direct | Holding | $0.65 exercise price | 2018-05-02 | ||
| 2018-05-02 holding as of filing | David Nathaniel E Director, Officer (President) | 3 | Series A-2 Warrant Derivative · Direct | Holding | $0.66 exercise price | 2018-05-02 | ||
| 2018-05-02 holding as of filing | David Nathaniel E Director, Officer (President) | 3 | Series A-2 Warrant Derivative · Direct | Holding | $0.66 exercise price | 2018-05-02 |